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rc-family kinases, known to participate in signaling
pathways of a variety of surface receptors, are localized
to the cytoplasmic side of the plasma membrane
through lipid modiﬁcation. We show here that Lyn, a member
of the Src-family kinases, is biosynthetically transported to
the plasma membrane via the Golgi pool of caveolin along
the secretory pathway. The trafﬁcking of Lyn from the Golgi
apparatus to the plasma membrane is inhibited by deletion of
the kinase domain or Csk-induced “closed conformation”
S
 
but not by kinase inactivation. Four residues (Asp346 and
Glu353 on 
 
 
 
E helix, and Asp498 and Asp499 on 
 
 
 
I helix)
present in the C-lobe of the kinase domain, which can be
exposed to the molecular surface through an “open confor-
mation,” are identiﬁed as being involved in export of Lyn
from the Golgi apparatus toward the plasma membrane but
not targeting to the Golgi apparatus. Thus, the kinase domain
of Lyn plays a role in Lyn trafﬁcking besides catalysis of
substrate phosphorylation.
 
Introduction
 
Src-family protein-tyrosine kinases, which belong to a family
of nonreceptor-type tyrosine kinases, comprise proto-oncogene
products and structurally related proteins, and include at
least eight members with significant amino acid sequence
homology (c-Src, Lyn, c-Yes, Fyn, c-Fgr, Hck, Lck, and
Blk). Src-family kinases are known to play crucial roles in
regulating proliferation and differentiation, especially cell
growth control, gene expression, metabolism, and cytoskeletal
architecture (Thomas and Brugge, 1997). Multiple combi-
nations of Src-family kinase members are expressed in many
cell types and are involved in individual and overlapping
signaling pathways (Korade-Mirnics and Corey, 2000).
Src-family kinases are composed of: (a) an NH
 
2
 
-terminal
Src homology (SH) 4 domain that contains lipid modification
sites for myristoylation mostly together with palmitoylation;
(b) a poorly conserved “unique” domain, which is hypervariable
among Src-family kinases; (c) an SH3 domain, which can
bind to specific proline-rich sequences; (d) an SH2 domain,
which can bind to specific sites of tyrosine phosphorylation;
(e) an SH1 tyrosine kinase catalytic domain; and (f) a
COOH-terminal negative regulatory tail for autoinhibition
of kinase activity (Brown and Cooper, 1996). The tyrosine
kinase activity of Src-family kinases is repressed through
creating a distinctive “closed conformation” due to the intra-
molecular bindings of the SH2 domain to the tyrosine-
phosphorylated tail catalyzed by the Csk-family and of the
SH3 domain to the SH2-kinase linker (Sicheri et al., 1997;
Xu et al., 1997). The absence of this COOH-terminal tyro-
sine residue, as found in the viral oncogenic forms, leads to
cell transformation due to constitutive kinase-activation by
derepression (Brown and Cooper, 1996; Blume-Jensen and
Hunter, 2001).
Src-family kinases, classified as cytosolic enzymes, are local-
ized at the cytoplasmic face of the plasma membrane through
posttranslational myristoylation (Resh, 1994), but an appre-
ciable fraction is found at the perinuclear region (Resh and
Erikson, 1985; David-Pfeuty and Nouvian-Dooghe, 1990),
which may correspond to associate with late endosomes
(Kaplan et al., 1992), and at other locations including synaptic
vesicles (Linstedt et al., 1992) and secretory granules/phago-
somes (Mohn et al., 1995). Previous studies on c-Src, Lck,
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Fyn, and Hck (David-Pfeuty and Nouvian-Dooghe, 1990;
Kaplan et al., 1992; Ley et al., 1994; Gauen et al., 1996; Bijl-
makers et al., 1997; van’t Hof and Resh, 1997; Bijlmakers
and Marsh, 1999; Carreno et al., 2000) elaborately explored
the localizations of the Src-family kinases by immunostaining
or pulse-radiolabeling and -chase experiments coupled with
subcellular fractionation. Although distinctive localizations of
individual members of Src-family kinases have been impli-
cated in their specific functions, the mechanism of their di-
verse intracellular localizations has thus far not been fully
provided. Therefore, we wished to examine how Src-family
kinases can localize and to determine which elements can
function for the localization.
Here, we chose Lyn that belongs to a member of the Src-
family kinases because Lyn is widely expressed in a variety of
organs, tissues, and cell types such as epidermoid, hemato-
poietic, and neuronal cells, and plays an important role in
signal transduction at the cytoplasmic side of the plasma
membrane (Tsukita et al., 1991; Radha et al., 1996; Healy
and Goodnow, 1998; Hirao et al., 1998; Hayashi et al.,
1999; Dykstra et al., 2001). To explore the basis that deter-
mines intracellular localization of Lyn, we took an approach
for spatial and temporal detection of Lyn and its mutants,
using an inducible or transient expression of Lyn or Lyn
fused with the GFP visualized by confocal laser microscopy.
Here, we show that Lyn is mainly localized to both the
plasma membrane and a fraction of caveolin, a marker for a
class of endosomes, which is present at the Golgi apparatus.
After biosynthesis, Lyn is rapidly associated with the Golgi
pool of caveolin, and then transported to the plasma mem-
brane. The trafficking of Lyn from the Golgi apparatus to the
plasma membrane requires the kinase domain per se but not
Figure 1. Perinuclear localization of 
Lyn and its mutants. (A) Schematic 
representations of Lyn and its mutants 
are shown with the Src homology (SH) 
domains, the negative-regulatory tyrosine 
(Y), and the HA-epitope tag. HeLa cells 
inducibly expressing Lyn-HA (B) or 
Lyn K-HA (C) were cultured in the 
absence (insets) or presence of 1  g/ml 
doxycycline for 2 d, and stained with anti-
HA. Lyn, green; DNA, red. Bars, 20  m. 
HeLa cells inducibly expressing Lyn-HA 
(D) or Lyn K-HA (E) were cultured in 
the presence of 3  g/ml doxycycline for 
the indicated periods, and stained with 
anti-HA. Cells exhibiting the perinuclear 
localization of Lyn as seen in C were 
quantified. Results (%) are the mean   
SD from three independent experiments. 
Protein expression was not detected 
until 3 h of induction. (F) COS-1 cells 
transfected with Lyn and its mutants 
were cultured for 24 h, stained with anti-
Lyn. Three patterns of Lyn localization 
are shown: PeriN (a, a , b, b ), PeriN   
PM (c, c ), and PM (d, d ), as described 
in Materials and methods. Arrows indicate 
the perinuclear region. Bars, 20  m. 
(G) A representative analysis of each 
Lyn mutant is shown. COS-1 cells trans-
fected with Lyn (a), Lyn-HA (b), or 
Lyn K-HA (c) were cultured for the 
indicated periods. Lyn localization was 
quantified according to the classification 
as described in F. PeriN, filled bars; PM, 
open bars. Protein expression was not 
detected until 11 h after transfection. 
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the kinase activity. We further identify four negative-charged
amino acid residues, which are conserved among Src-family
kinases and aligned on one side of the C-lobe of the kinase
domain, responsible for the trafficking of Lyn to the plasma
membrane. Our findings demonstrate the significance of the
C-lobe through an open conformation for export of Lyn
from the Golgi apparatus to the plasma membrane.
 
Results
 
Predominant localization of Lyn to the perinuclear 
region caused by kinase-domain deletion
 
To explore an element that can affect subcellular localization
of Lyn, we examined the localization of a kinase-active Lyn
mutant (Lyn-HA) and a kinase-domain deleted Lyn mutant
(Lyn
 
 
 
K-HA; Fig. 1 A) by generating HeLa cell clones that
express Lyn-HA or Lyn
 
 
 
K-HA in an inducible manner.
When induced by addition of doxycycline, a tetracycline de-
rivative, Lyn-HA was detected at the plasma membrane and
the perinuclear region (Fig. 1 B), whereas Lyn
 
 
 
K-HA was
predominantly seen in the perinuclear region (Fig. 1 C).
Until 3 h after induction, protein expression could not be
detected by our immunostaining. In the course of induction,
a majority of Lyn-HA was initially observed in the perinu-
clear region and subsequently detected at the plasma mem-
brane (Fig. 1 D), whereas Lyn
 
 
 
K-HA was almost restricted
to the perinuclear region during the observation period (Fig.
1 E). These results suggest that upon expression Lyn may
initially become accumulated at the perinuclear region, and
that its subsequent appearance at the plasma membrane may
involve the kinase domain.
Furthermore, transient expression of Lyn and its mutants
in COS-1 cells enabled us to classify their features of local-
ization as three patterns (PeriN, PeriN 
 
  
 
PM, and PM) on
the basis of ratios in amounts of expressed proteins between
the perinuclear region (PeriN) and the plasma membrane
(PM) (Fig. 1 F; see Materials and methods). Fig. 1 G shows
that (a) Lyn, (b) Lyn-HA, and (c) Lyn
 
 
 
K-HA irrespective of
the difference in structure were predominantly observed in
the perinuclear region during the earlier phase of expression.
In the later phase, a majority of Lyn and Lyn-HA were ob-
served at the plasma membrane, whereas an appreciable frac-
Figure 2. Colocalization of Lyn with the Golgi pool of caveolin at the perinuclear region. COS-1 cells were transfected with Lyn, and stained 
with anti-Lyn (red) in conjunction with (A) anti-galactosyltransferase (anti-GalT; green) or (B) anti-caveolin (green). All Z-series sections at 
0.3–0.5- m intervals were merged in two-dimensional xy images. Orthogonal sections viewing axial directions (xz and yz) are created in the 
margins. (C and D) COS-1 cells transfected with Lyn-HA were cultured for 18 h in the presence or absence of 200  g/ml CHX during the last 3 h. 
Cells were double stained with anti-Lyn (red) and anti-caveolin (green). (D) Cells exhibiting the perinuclear localization of Lyn were quantified. 
Results (%) are the mean   SD from three independent experiments. (E) HeLa cells were incubated in the absence (top) or presence (bottom) 
of 5  g/ml BFA for 1 h. Cells were double stained with anti-Lyn (red) and anti-GalT (green). N, nucleus. Bars, 20  m. 
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tion of Lyn
 
 
 
K-HA still resided in the perinuclear region.
These results are consistent with the results of HeLa cells
shown in Fig. 1 (D and E).
 
Spatial association of Lyn with caveolin at the 
Golgi apparatus
 
To characterize the perinuclear region, cross sections of the
confocal images were acquired in the z axis. Fig. 2 A shows
that a large fraction of perinuclear Lyn was colocalized with
 
 
 
-1,4-galactosyltransferase (GalT), a trans-Golgi resident
protein. Notably, Lyn was precisely colocalized with caveo-
lin in the perinuclear region whereas Lyn and caveolin were
poorly colocalized at the plasma membrane (Fig. 2 B). These
results indicate that Lyn is colocalized with a pool of caveo-
lin at the Golgi apparatus.
The recent data suggest that the presence of the Golgi
pool of caveolin is dependent on new protein synthesis and
not on exchange with caveolin at the plasma membrane or
in endosomes (Nichols, 2002). To examine the relationship
between Lyn and caveolin at the Golgi apparatus, cells were
treated with cycloheximide (CHX), an inhibitor of protein
synthesis. As shown in Fig. 2 (C and D), treatment of Lyn-
expressing cells with CHX emptied caveolin from the Golgi
apparatus, which was accompanied by elimination of peri-
nuclear Lyn. However, CHX treatment did not disturb lo-
calization of Lyn to the plasma membrane. Given that Lyn
and caveolin were poorly colocalized at the plasma mem-
brane (Fig. 2 B), these results implicate that Lyn may be
temporarily associated with caveolin at the Golgi apparatus
before its reach to the plasma membrane.
Next, to examine whether localization of endogenous
Lyn was similar to that of overexpressed Lyn, we immun-
ostained HeLa and COS-1 cells with anti-Lyn. As shown
in Fig. 2 E (top), endogenous Lyn was colocalized with
Figure 3. Lyn trafficking through the 
Golgi pool of caveolin after biosynthesis. 
Lyn trafficking was visualized in living 
COS-1 cells that were transfected with 
Lyn-GFP and cultured for 1 d. (A, a) 
Whole area of a cell was bleached, and 
the cell was monitored for the next 50 
min at 20-s intervals. Times are shown 
from completion of the photobleaching. 
(b) Quantification of fluorescence 
recovery in the perinuclear region (circled 
area) and the plasma membrane (boxed 
area). Mean fluorescence intensities of 
recovery after photobleaching are plot-
ted versus time. (B) (a) The perinuclear 
region (circled area) was bleached, and 
then the cell was monitored for the next 
40 min at 20-s intervals in the absence 
or presence of 200  g/ml CHX from 1 h 
before bleaching. (b) Quantification of 
fluorescence recovery in the perinuclear 
region (circled area). (C, a) Whole cell 
area excluding the perinuclear region 
was bleached, and then the cell was 
monitored for the next 30 or 60 min at 
2-min intervals in the absence or presence 
of 300  M NEM from 15 min before 
photobleaching. (b) Quantification of 
fluorescence recovery in the plasma 
membrane (boxed areas). (D) Whole cell 
area including the perinuclear region 
was bleached, and then the cell was 
cultured for 60 min in the presence of 
300  M NEM from 15 min before photo-
bleaching. N, nucleus. Bars, 20  m. 
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GalT in HeLa cells as observed in Lyn-transfected COS-1
cells (Fig. 2 A). Although endogenous Lyn was detected in
COS-1 cells by Western blotting, it could not be visualized
by our immunostaining probably due to lower expression
(unpublished data). We then tested the localization of en-
dogenous Lyn for sensitivity to brefeldin A (BFA), because
BFA is known to cause disassembly and redistribution of
the Golgi apparatus into the ER (Klausner et al., 1992).
Fig. 2 E (bottom) shows that endogenous Lyn present at
the Golgi apparatus was dispersed by BFA treatment in ac-
cordance with redistribution of GalT into the ER. The dis-
persal of Lyn from the Golgi apparatus was also observed
in Lyn-HA–expressing COS-1 cells (Fig. 7 A). These re-
sults suggest that both endogenous Lyn and overexpressed
Lyn are similarly localized to the Golgi apparatus in a BFA-
sensitive manner.
 
Trafficking of newly synthesized Lyn through the Golgi 
apparatus toward the plasma membrane
 
The Lyn-GFP fusion protein contains the almost entire
structure of Lyn-HA, including the NH
 
2
 
-terminal lipid at-
tachment sites for myristoylation and palmitoylation, and is
likely to preserve all functions of Lyn-HA. Indeed, the local-
ization of Lyn-GFP visualized by fluorescence of GFP or
anti-Lyn immunostaining was consistent with that of Lyn-
HA detected by anti-Lyn or anti-HA immunostaining (un-
published data). Using FRAP techniques, the trafficking of
Lyn-GFP after biosynthesis was monitored in living COS-1
cells transfected with Lyn-GFP. When whole cell area was
photobleached, rapid recovery of Lyn-GFP fluorescence was
observed in both the perinuclear region (Fig. 3 A, circled
area) and the plasma membrane (Fig. 3 A, boxed area). In
particular, the recovery rate of Lyn-GFP fluorescence in the
perinuclear region was much higher than that at the plasma
membrane. Upon expression of adequate levels of Lyn-GFP
mRNA, FRAP can ensure rapid detection of trafficking of
Lyn-GFP just after biosynthesis. The apparently slow kinet-
ics (Fig. 1, D–G) could be explained by our inability to im-
munodetect Lyn proteins at low levels of Lyn mRNA during
the early phase of induction.
When perinuclear Lyn-GFP was selectively photobleached,
rapid recovery of Lyn-GFP fluorescence was observed in the
perinuclear region (Fig. 3 B). In sharp contrast, treatment
with CHX completely blocked recovery of perinuclear Lyn-
GFP after the selective photobleaching of the perinuclear
region. These results indicate that the appearance of Lyn at
the Golgi apparatus requires protein biosynthesis, suggesting
that Lyn barely recycles from the plasma membrane to the
Golgi apparatus.
To test whether vesicular transport was required for lo-
calization of Lyn-GFP to the plasma membrane, we used
 
N
 
-ethyl-maleimide (NEM), a reagent known to block a wide
Figure 4. Inhibition of Lyn trafficking by Csk, 
but not by Lyn inactivation. (A) COS-1 cells 
transfected with Lyn, Lyn plus Csk, Lyn-HA, or 
Lyn(K275A)-HA were cultured for 24 h, and stained 
with anti-Lyn or anti-HA. COS-1 cells transfected 
with Lyn were cultured for 24 h, and treated 
with or without 10  M PP2. Lyn localization was 
classified as described in Fig. 1 F. Results (%) are 
the mean   SD from three independent experi-
ments. COS-1 cells transfected with Lyn-HA plus 
Csk were cultured for 24 h. Results (%) of a 
representative experiment are shown for localization 
of Lyn-HA. PeriN, filled bars; PM, open bars. 
(B) COS-1 cells transfected with Lyn (a) or Lyn plus 
Csk (b) were cultured for 24 h, and stained with 
anti-Lyn. Arrows indicate cells expressing Lyn. 
Lyn, green; DNA, red. Bars, 20  m. (C) Lyn immuno-
precipitates prepared from COS-1 cells transfected 
with Lyn or Lyn plus Csk were subjected to in vitro 
kinase assays. Kinase reactions were determined 
by probing with anti-pTyr, and amounts of Lyn 
immunoprecipitates were analyzed by subsequent 
reprobing with anti-Lyn. The levels of tyrosine 
phosphorylation of enolase relative to the amounts 
of Lyn at each reaction time were quantified. 
Results are the mean   SD from three independent 
kinase assays. (D) COS-1 cells were transfected 
with Lyn-HA or Lyn(K275A)-HA and cultured for 
48 h. (Top) Western blot of equal amounts of 
Triton X-100 lysates was probed with anti-pTyr, 
and subsequently reprobed with anti-Lyn. The 
positions of size markers in kilodaltons are shown 
on the right. (Bottom) Immunoprecipitates of Lyn 
mutants with anti-HA were probed with anti-pTyr, 
and amounts of the immunoprecipitates were 
analyzed by subsequent reprobing with anti-HA. 
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range of vesicular fusion events (Bivona et al., 2004). Fluores-
cence recovery of Lyn-GFP was monitored in the absence or
presence of NEM after whole cell area excluding the peri-
nuclear region was photobleached. As shown in Fig. 3 C,
treatment of Lyn-GFP–expressing cells with NEM strongly
blocked fluorescence recovery of Lyn-GFP at the plasma
membrane (boxed area). Photobleaching of whole cell area in
the presence of NEM ensured fluorescence recovery of Lyn-
GFP at the perinuclear region (Fig. 3 D). These results sug-
gest that newly synthesized Lyn is initially transported to the
Golgi apparatus by nonvesicular transport but not targeted
directly to the plasma membrane, and that the trafficking of
Lyn from the Golgi apparatus en route to the plasma mem-
brane is mediated by exocytic vesicular transport.
 
Requirement of the kinase domain but not kinase 
activity for Lyn trafficking to the plasma membrane
 
The catalytic activity of Src-family kinases is inhibited by
creating a “closed conformation” through Csk tyrosine ki-
nase-mediated phosphorylation of the COOH-terminal ty-
rosine residue (Brown and Cooper, 1996). To examine
whether the kinase activity was required for localization of
Lyn to the plasma membrane, we cotransfected COS-1 cells
with Lyn and Csk. Their concomitant expression was found
to increase the localization of Lyn to the Golgi apparatus
and to decrease that to the plasma membrane (Fig. 4, A and
B). In vitro kinase assays verified the inhibition of Lyn ki-
nase activity by coexpressed Csk (Fig. 4 C). Localization of
Lyn-HA, which is devoid of the COOH-terminal tyrosine
residue, to the plasma membrane was unaffected by Csk co-
expression (Fig. 4 A), indicating the inhibition through Csk-
mediated phosphorylation of the COOH-terminal tyrosine
residue of Lyn.
We then created a kinase-inactive mutant, Lyn(K275A)-
HA by replacing Lys-275 to alanine in the ATP-binding
site. Fig. 4 D confirmed that Lyn(K275A)-HA was deficient
in tyrosine kinase activities for phosphorylation of cellular
proteins and autophosphorylation. To our surprise, localiza-
tion of Lyn(K275A)-HA was essentially similar to that of
Lyn-HA (Fig. 4 A). Furthermore, treatment with PP2, a Src
inhibitor that accesses a hydrophobic pocket-structure near
the ATP-binding cleft of Src-family kinases (Zhu et al.,
1999), was unable to inhibit localization of Lyn to the
plasma membrane (Fig. 4 A), although the kinase activity of
Lyn was greatly reduced (not depicted). These findings dem-
onstrate that the kinase domain per se but not the kinase ac-
tivity plays an important role in localization of Lyn to the
plasma membrane.
 
The C-lobe responsible for Lyn trafficking to the 
plasma membrane
 
To identify a structure or an element in the kinase domain
responsible for the localization, we constructed various dele-
tion mutants of Lyn-HA and analyzed the expressed pro-
teins in COS-1 cells by Western blotting. As shown in Fig. 5
A, each of these mutant proteins was detected at the ex-
pected size and the expression level of each protein was com-
parable. Fig. 5 B provides evidence that the localization of
Lyn to the plasma membrane involves the structure encom-
passing amino acids 236–506 in Lyn-HA, suggesting the
importance of the NH
 
2
 
- and COOH-terminal lobes of the
kinase domain. However, the crystal structures of Hck and
c-Src indicate that the 
 
 
 
A helix in the SH2 domain electro-
statically interacts with the 
 
 
 
E and 
 
 
 
I helices in the C-lobe
of the kinase domain (Fig. 6 A; Xu et al., 1997; Sicheri et al.,
1997). If electrostatic interactions between the SH2 domain
and the C-lobe are extremely strengthened by deletion of
both the SH2 linker and the N-lobe that might function as
a spring hinge, one would predict that the SH2 domain
tightly masks an element on the C-lobe responsible for
plasma membrane localization. Therefore, we created the
Lyn mutant (
 
 
 
 121-324) by deletion of the SH2 domain,
the SH2 linker and the N-lobe (Fig. 5 A). Fig. 5 C reveals
that, like Lyn-HA, the Lyn mutant (
 
 
 
 121-324) was initially
Figure 5. Involvement of the COOH-terminal kinase lobe in Lyn 
trafficking. (A) Schematic representations of Lyn-HA and its deletion 
mutants are shown. COS-1 cells were transfected with each of Lyn 
mutants, and cultured for 48 h. Western blots of equal amounts of 
Triton X-100 lysates were probed with anti-Lyn or anti-HA. Asterisks 
indicate the expressed proteins. (B) After transfection with each of 
Lyn mutants, COS-1 cells were cultured for 48 h. Results (%) of 
localization of Lyn mutants are the mean   SD from three independent 
experiments, as described in Fig. 1 F. (C) Results (%) of localization 
of   121-324 at 12 and 48 h after transfection into COS-1 cells are 
shown from a representative and three independent experiments, 
respectively. PeriN, filled bars; PM, open bars. 
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accumulated at the Golgi apparatus and was then able to ef-
ficiently localize to the plasma membrane. This indicates
that the N-lobe is dispensable for the plasma membrane lo-
calization. It should be noted that the 
 
 
 
E and 
 
 
 
I helices are
positioned side by side on the same surface of the C-lobe
(Fig. 6 A). Therefore, it is likely that the 
 
 
 
E and 
 
 
 
I helices
present on the C-lobe are candidate structures that could be
only exposed to the molecular surface of Lyn in an “open
conformation” but be masked in a “closed conformation”
induced by Csk phosphorylation.
 
Identification of four negative-charged residues 
on the C-lobe
 
The overall organization of c-Src and Hck (Fig. 6 A) and the
interaction of the SH2 and catalytic domains (Fig. 6 B) were
provided (Sicheri et al., 1997; Xu et al., 1997; Williams et
al., 1998). Structure-based amino acid sequence alignment
indicates that three positive-charged residues on the 
 
 
 
A he-
lix in the SH2 domain and four negative-charged residues
aligned on one side of the 
 
 
 
E and 
 
 
 
I helices in the C-lobe
are conserved among members of the Src family (Fig. 6 C),
predicting that Lyn, similar to c-Src and Hck, is structurally
organized with the 
 
 
 
A helix (Arg-136, Lys-137 and Arg-
141) in the SH2 domain, and with the 
 
 
 
E (Asp-346 and
Glu-353) and 
 
 
 
I (Asp-498 and Asp-499) helices in the
C-lobe.
We created three alanine-substitution mutants of the
C-lobe, DE-mt, DD-mt, and Tetra-mt, as depicted in Fig.
6 D. The levels of protein expression and kinase activity
for autophosphorylation were comparable in COS-1 cells
transfected with Lyn-HA or each Lyn mutant (Fig. 6 E). In-
triguingly, mutations of the negative-charged residues were
found to inhibit the localization of Lyn-HA to the plasma
membrane in both COS-1 cells and HeLa cells (Fig. 6 F).
Among DE-mt, DD-mt, and Tetra-mt, Tetra-mt exhibited
the maximum inhibition of plasma membrane localization,
which closely corresponded to the data of Lyn(
 
 
 
 236-298)
as a control (Fig. 5 B, compare 
 
 
 
 236-298 with 
 
 
 
K-HA).
These results suggest that the four negative-charged residues
in the C-lobe play a role in the trafficking of Lyn-HA to the
plasma membrane.
 
Role of four negative-charged residues in the C-lobe 
in the trafficking of Lyn
 
Next, we examined whether localization of Lyn-HA and
Tetra-mt was affected by treatment with BFA. Fig. 7 B
shows that Tetra-mt, like Lyn-HA (Fig. 7 A, top), was colo-
calized with GalT in the absence of BFA. The levels of
Tetra-mt that were accumulated at the Golgi apparatus ap-
peared to be slightly higher than those of Lyn-HA as judged
by fluorescence intensities (Fig. 7, compare B with A). Upon
treatment with BFA, Tetra-mt and Lyn-HA were both dis-
persed from the Golgi apparatus in the same way (Fig. 7, A
and B, bottom). These results suggest that the association of
Lyn with the Golgi apparatus may be unaffected by the mu-
tation in the C-lobe.
To examine whether the four negative-charged residues in
the C-lobe were involved in transport of Lyn from the Golgi
apparatus to the plasma membrane and/or accumulation of
Lyn at the Golgi apparatus, we constructed the GFP-tagged
version of Tetra-mt (Tetra-mt-GFP) by replacing Asp-346,
Glu-353, Asp-498, and Asp-499 present in the C-lobe of
Lyn-GFP with four alanines. The pattern of localization of
Tetra-mt-GFP to the Golgi apparatus was indistinguishable
from that of Tetra-mt (unpublished data; Fig. 6 F). Then,
we compared the trafficking of Lyn-GFP with that of Tetra-
mt-GFP. Using FRAP, fluorescence recovery of Lyn-GFP or
Tetra-mt-GFP was simultaneously monitored in both the
perinuclear region (Fig. 7, C and D, circled area) and the
plasma membrane (Fig. 7, C and D, boxed area) after whole
Figure 6. Inhibition of Lyn trafficking by mutation of four charged 
amino acid residues. (A) Src structure in the inactive state, represented 
by the SH3 (green) and SH2 (yellow) domains, the SH2 linker (red), 
the NH2-terminal (light blue) and COOH-terminal (purple) kinase 
lobes, and the COOH-terminal tail (orange). (B) The interaction of 
the COOH-terminal kinase lobe and the SH2 domain via positively 
(green) and negatively (red) charged side chains in Hck. The figures 
(A and B) are modified from Sicheri et al. (1997) and Williams et al. 
(1998). (C) Amino acid sequence alignment of the Src family, the 
Csk family (Csk and Chk), c-Abl, insulin receptor kinase (IRK), fibro-
blast growth factor receptor kinase (FGFRK), and cAMP-dependent 
protein kinase (PKA). Positively and negatively charged residues are 
shown in green and red, respectively. (D) Schematic representations 
of Lyn-HA and its alanine-substitution mutants are shown. (E) COS-1 
cells were transfected with Lyn mutants, and cultured for 48 h. 
Western blot of equal amounts of Triton X-100 lysates was probed 
with anti-pTyr, and subsequently reprobed with anti-HA and anti-
actin. (F) COS-1 cells (left) or HeLa cells (right) were transfected with 
Lyn mutants, and cultured for 48 h. Results (%) of Lyn localization 
are the mean   SD from three independent experiments, as described 
in Fig. 1 F. PeriN, filled bars; PM, open bars. 
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Figure 7. Involvement of the four 
charged residues in transport of Lyn 
from the Golgi to the plasma membrane. 
COS-1 cells transfected with Lyn-HA (A) 
or Tetra-mt (B) were cultured for 1 d in 
the absence or presence of 5  g/ml BFA 
during the last 1 h. Cells were double 
stained with anti-Lyn (red) and anti-GalT 
(green). (C and D) Lyn trafficking was 
visualized in living COS-1 cells trans-
fected with Lyn-GFP (C) or Tetra-mt-GFP 
(D). (a) Whole area of a cell was bleached, 
and the cell was monitored for the next 
90–110 min at 2-min intervals. Times 
are shown from completion after the 
photobleaching. (b) Quantification of 
fluorescence recovery in the perinuclear 
region (circled area) and the plasma 
membrane (boxed area). Mean fluores-
cence intensities of recovery after 
photobleaching are plotted versus time. 
N, nucleus. Bars, 20  m. 
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cell area was photobleached. Fig. 7 C shows that rapid re-
covery of Lyn-GFP fluorescence was observed in the perinu-
clear region (circled area). This rapid response was similar to
that of fluorescence recovery of Tetra-mt-GFP in the peri-
nuclear region (Fig. 7 D, circled area). The plateau levels in
fluorescence recovery were also comparable between Lyn-
GFP and Tetra-mt-GFP (Fig. 7, C and D, circled area). In
sharp contrast to the perinuclear region, the rate of fluores-
cence recovery of Tetra-mt-GFP at the plasma membrane
(Fig. 7 D, boxed area) greatly decreased as compared with
that of Lyn-GFP at the plasma membrane (Fig. 7 C, boxed
area). These results suggest that the mutation of the four
charged residues is unlikely to affect the association of Lyn at
the Golgi apparatus just after biosynthesis. Rather, the mu-
tation markedly impeded the trafficking of Lyn from the
Golgi apparatus toward the plasma membrane. These results
implicate that the four negative-charged residues on the
C-lobe may be involved in an export process of Lyn from
the Golgi apparatus.
 
Discussion
 
Here, we demonstrate that the kinase domain of Lyn plays a
significant role in Lyn trafficking besides catalysis of sub-
strate phosphorylation. By using FRAP and immunostain-
ing for pursuing spatial and temporal localization of Lyn, we
show that newly synthesized Lyn is accumulated at the Golgi
pool of caveolin and then transported to the plasma mem-
brane in a kinase domain-dependent but kinase activity-
independent manner. Furthermore, we have identified four
negative-charged amino acid residues in the C-lobe of the
kinase domain as being important for transport of Lyn from
the Golgi apparatus toward the plasma membrane.
It is well known that nonreceptor-type tyrosine kinases
contain modular domains for protein–protein interactions,
such as the SH2 and SH3 domains (Pawson, 1995). In the
repressed state, the SH2 and SH3 domains of Src-family ki-
nases and of Abl tyrosine kinase can confer their autoinhib-
ited “closed conformation” through intramolecular interac-
tions (Sicheri et al., 1997; Xu et al., 1997; Hantschel et al.,
2003; Nagar et al., 2003). In the activated state, these mod-
ular domains exposed by an “open conformation” can inter-
act with adaptor or substrate proteins, thereby transmitting
signals downstream. It should be noted that the trafficking
of Lyn can be inhibited by Csk-mediated phosphorylation of
the COOH-terminal tyrosine residue of Lyn (Fig. 4, A–C).
Nonetheless, the trafficking of the kinase-inactive Lyn mu-
tant obviously proceeds to the plasma membrane (Fig. 4).
Therefore, we assume a novel Csk-induced mechanism for
inhibition of Lyn trafficking, independently of the kinase-
activity inhibition, which could not be explained by the
well-established autoinhibition mechanism (Brown and Coo-
per, 1996; Gonfloni et al., 1999; Hubbard, 1999; Xu et
al., 1999). Mutational analyses further reveal that the four
negative-charged amino acid residues of the C-lobe in the
kinase domain, which may be exposed to the molecular sur-
face in an “open conformation” (Fig. 6 A), is involved in the
trafficking of Lyn from the Golgi apparatus to the plasma
membrane (Fig. 6 F and Fig. 7). Accordingly, we hypothe-
size that an “open conformation” of Lyn unmasks the 
 
 
 
E
and 
 
 
 
I helices within the C-lobe of the kinase domain in-
cluding the four negative-charged amino acid residues that
may function for the proper trafficking through potential
protein–protein interactions.
Treatment with BFA disperses the Golgi localization of
Lyn, accompanied by disassembly of the Golgi apparatus
(Fig. 2 E; Fig. 7, A and B), suggesting that the transport of
Lyn to the plasma membrane may share membrane transport
via the Golgi apparatus in the secretory pathway. The obser-
vations of whole cell bleaching in FRAP experiments indi-
cate that the localization of Lyn to the Golgi apparatus ap-
pears to precede plasma membrane localization (Fig. 3 A).
Furthermore, inhibition of protein synthesis shows that the
localization of Lyn at the Golgi apparatus actually requires
protein synthesis (Fig. 3 B), suggesting that Lyn already
transported to the plasma membrane does not move back
from the plasma membrane to the Golgi apparatus. Intrigu-
ingly, the export of Lyn from the Golgi apparatus to the
plasma membrane is specifically inhibited by treatment with
NEM (Fig. 3, C and D), further indicating that the trans-
port is assisted with membrane vesicles of the exocytic path-
way. The C-lobe of the kinase domain is involved in export
of Lyn from the Golgi apparatus to the plasma membrane
(Figs. 6 and 7), whereas the SH4, unique, SH3 and SH2 do-
mains are not (Fig. 5). Together, we can imagine that local-
ization of Lyn to the Golgi apparatus is prerequisite for its
trafficking to the plasma membrane along the exocytic vesic-
ular transport pathway, i.e., one-way or vectorial trafficking
of Lyn through the Golgi apparatus. Perhaps the C-lobe may
actively participate in and accelerate an export process on the
cytoplasmic side of vesicles at the Golgi apparatus, because
Lyn must be anchored on the outer surface of membrane
vesicles through lipid modification. Alternatively, given that
accumulation of newly synthesized Lyn at the Golgi appara-
tus can reach a plateau at similar rates and levels irrespective
of the mutation of four negative-charged residues on the
C-lobe (Fig. 7, C and D), Lyn might be protected from pro-
teolytic degradation in the Golgi milieu due to the negative-
charged residues on the C-lobe. Further studies will decipher
a precise role of the C-lobe in Lyn trafficking.
Caveolins form lipid-raft platforms of a variety of signal-
ing molecules at the plasma membrane and are important
for transporting cholesterol and glycosylphosphatidylinosi-
tol-linked proteins (Liu et al., 2002). Caveolins are also in-
volved in endocytic and exocytic transport (Scheiffele et al.,
1998; Pelkmans et al., 2001; Nichols, 2002). Caveolin-con-
taining endosomes are implicated as sites for the sorting
of caveolin away from the Golgi-bound cargos (Nichols,
2002). Our cross sections of the confocal images demon-
strate that Lyn colocalizes with caveolin at the Golgi appara-
tus (Fig. 2, A and B). It is of substantial interest to note that
minimal colocalization of Lyn with caveolin is detected at
the plasma membrane despite flawless colocalization of Lyn
with caveolin at the Golgi apparatus (Fig. 2, B and C). Al-
though a role of caveolin in Lyn trafficking is still unclear,
Lyn may be dissociated from caveolin-containing vesicles
during transport of Lyn from the Golgi apparatus en route
to the plasma membrane.
Mutation of the COOH-terminal tyrosine residue or de-
letion of the kinase domain of c-Src was reported to dramat- 
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ically redistribute c-Src from perinuclear endosomal mem-
branes to focal adhesions (Kaplan et al., 1994), suggesting
that the SH2 and SH3 domains of c-Src in an “open confor-
mation” can be exposed for association with focal adhesions.
However, despite the presence of the SH4, unique, SH3 and
SH2 domains, the localization of the kinase domain-deleted
Lyn (Lyn
 
 
 
K-HA) to the perinuclear region (Fig. 1) is quite
different from that of the kinase domain-deleted c-Src to fo-
cal adhesions. Even though the COOH-terminal negative
tyrosine residue of Lyn is mutated for formation of an acti-
vated “open conformation,” the pattern of localization of
Lyn-HA is dissimilar to that of the corresponding mutant of
c-Src (Fig. 1; for review see Kaplan et al., 1994). Thus far, it
has been reported that c-Src, Lck, Fyn, Hck, and c-Yes are
enriched in the perinuclear region (Resh and Erikson, 1985;
David-Pfeuty and Nouvian-Dooghe, 1990; Kaplan et al.,
1992; Ley et al., 1994; Gauen et al., 1996; Bijlmakers et
al., 1997; Carreno et al., 2000; McCabe and Berthiaume,
2001). In our view emerged from literature surveys, the lo-
calizations of Lck and Hck to the perinuclear region seem to
be similar to the restricted localization of Lyn shown in this
work, whereas c-Src and c-Yes appear to be more widely dis-
tributed around the nucleus. In fact, we observed minimal
colocalization of c-Src with caveolin in the perinuclear re-
gion and no elimination of c-Src from the perinuclear region
by inhibition of protein synthesis (Fig. 2, C and D; unpub-
lished data). These results raise the intriguing possibility that
two close relatives, Lyn and c-Src, localize to at least two dif-
ferent subcellular organelles in the perinuclear region, i.e.,
the Golgi pool of caveolin and caveolin-negative endosomes,
for their presumable distinct functions.
Why does newly synthesized Lyn initially localize and ac-
cumulate at the Golgi apparatus? Recent evidence provides
a novel view that endomembranes, such as the Golgi ap-
paratus and the ER, may serve as a platform of signaling
molecules. For example, Ras that is restricted to the endo-
membranes can activate the Erk pathway in response to
mitogenic stimulation and play a role in transformation of
fibroblasts (Chiu et al., 2002). It is also observed that phos-
phatidylinositol-3,4,5-trisphosphate levels are increased to a
larger extent at the endomembranes than at the plasma
membrane, which is triggered by endocytosed receptor tyro-
sine kinases (Sato et al., 2003). Therefore, it would be
tempting to assume that accumulation of Lyn at the Golgi
apparatus is important in unidentified signal transduction at
endomembranes. Alternatively, previous studies with T cells
suggested that Lck can associate with the cytoplasmic do-
main of the cell surface transmembrane protein CD4 at the
Golgi apparatus early after synthesis or long before CD4 has
reached the plasma membrane (Bijlmakers et al., 1997; Bijl-
makers and Marsh, 1999). In addition, dual myristoylation
and palmitoylation are needed for membrane association,
because myristoylated proteins are either soluble or only
weakly associated with membranes (Resh, 1999) after the
covalent attachment of myristic acid to an NH
 
2
 
-terminal
glycine at the amino acid position 2 occurs cotranslationally
in the cytoplasm (Wilcox et al., 1987). Another possibility
may be addressed that a site of palmitoylation of Lyn might
be located in the Golgi apparatus because a species of palmi-
toyl acyltransferase is hypothesized to reside at the Golgi ap-
paratus (Bijlmakers and Marsh, 2003). Although these
possibilities are mutually inclusive, further studies will be re-
quired to understand a key role for localization of Lyn to the
Golgi apparatus besides the plasma membrane.
It is clear from this work that transport of Lyn to the
plasma membrane is far more complex than initially thought.
It should be emphasized that a structure of the kinase domain
per se plays a novel role for Lyn trafficking. At present, it is
particularly interesting to determine how an “open confor-
mation” of the kinase domain operates during protein traf-
ficking. In addition, the mechanisms of trafficking should be
compared between Lyn and c-Src for further understanding
of different localizations of these Src-family kinases.
 
Materials and methods
 
Plasmid constructs
 
Lyn lacking the kinase domain (Lyn
 
 
 
K, 1-298; the number referring to the
amino acid position from the initiator methionine) was constructed (Hirao
et al., 1998) from human wild-type p56 Lyn cDNA (Yamanashi et al.,
1987; provided by T. Yamamoto, University of Tokyo, Tokyo, Japan).
Lyn
 
 
 
K was ligated into the pMH vector (Roche), resulting in the HA-
tagged version (Lyn
 
 
 
K-HA). The HA-tagged kinase-active Lyn (Lyn-HA)
was designed to replace the COOH-terminal negative regulatory region
(507-512 containing Tyr508) with the HA epitope by PCR using the sense
primer 5
 
 
 
-AGATGAGCTCTATGACATTATGAA-3
 
 
 
 and the antisense
primer 5
 
 
 
-TTTCTAGAGTCTAAGCGTAGTCTGGGACGTCGTATGGGTA-
ACCTTCCGTGGCTGTGTAGAAA-3
 
 . The Lys→Ala mutation at position
275 in the ATP-binding site (kinase-inactive, K275A) was generated by site-
directed mutagenesis according to the protocol (Stratagene) with Lyn-HA as
a template using the sense primer 5 -CTATAACAACAGTACTAAGGTGGCT-
GTGGCAACCCTGAAGCCAGG-3  and the antisense primer 5 -CCTG-
GCTTCAGGGTTGCCACAGCCACCTTAGTACTGTTGTTATAG-3 . DE-mt
(Asp346→Ala, Glu353→Ala) and DD-mt (Asp498→Ala, Asp499→Ala)
were created using Lyn-HA as a template with the respective primer combi-
nations: the sense primer 5 -CAAAGCTCATTGCCTTTTCTGCGCAGATTG-
CAGCGGGAATGGCATAC-3  and the antisense primer 5 -GTATGCCAT-
TCCCGCTGCAATCTGCGCAGAAAAGGCAAGAGCTTTG-3 ; or the sense
primer 5 -GACTACTTACAGAGCGTGCTAGCTGCTTTCTACACAGCCA-
CGG-3  and the antisense primer 5 -CCGTGGCTGTGTAGAAAGCAG-
CTAGCACGCTCTGTAAGTAGTC-3 . Tetra-mt (Asp346→Ala, Glu353→Ala,
Asp498→Ala, Asp499→Ala) was constructed from DE-mt and DD-mt.  
458-512 (1-457),   368-512 (1-367),   297-457 (1-296 and 458-506),  
236-298 (1-235 and 299-506), and   121-324 (1-120 and 325-506) were
generated from Lyn-HA using appropriate restriction enzymes and blunting.
The resulting fragments were all confirmed by sequencing. Lyn-GFP and
Tetra-mt-GFP was constructed by fusion with GFP obtained from pEGFP-C1
(CLONTECH Laboratories, Inc.) at the COOH terminus of Lyn-HA and
Tetra-mt, respectively. The constructs were subcloned into the pMKITneo
vector (provided by K. Maruyama, Tokyo Medical and Dental University,
Tokyo, Japan) or the tetracycline-inducible pcDNA4/TO vector (Invitrogen).
Rat Csk cDNA (Nada et al., 1991; provided by M. Okada and S. Nada,
Osaka University, Osaka, Japan), tagged with the HA-epitope at the COOH
terminus into the pMH vector (Csk-HA, 1-440), was ligated into the pCAG
vector (Niwa et al., 1991; provided by J. Miyazaki, Osaka University).
Antibodies
Monoclonal anti-HA (F-7; Santa Cruz Biotechnology, Inc., and 3F10;
Roche), anti-Lyn (H-6; Santa Cruz Biotechnology, Inc.), antiphos-
photyrosine (anti-pTyr; 4G10; Upstate Biotechnology), and anti-actin
(MAB1501; CHEMICON International, Inc.) were used. Affinity-purified
rabbit anti-GalT (Yamaguchi and Fukuda, 1995; provided by M.N.
Fukuda, The Burnham Institute, La Jolla, CA), anti-Lyn (H-44; Santa Cruz
Biotechnology, Inc.), and anti-caveolin (Transduction) were used. HRP-
F(ab’)2 of antibodies to mouse, rat, or rabbit Ig were purchased from Amer-
sham Biosciences. FITC-F(ab’)2 of anti–rabbit IgG or of anti–mouse IgG
and TRITC-anti–mouse IgG were obtained from Biosource International
and Sigma-Aldrich.
Cells and transfection
COS-1 cells and HeLa cells (Japanese Collection of Research Bioresources)
were cultured in Iscove’s modified DME containing 5% FBS. T-REx
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HeLa cells (Invitrogen) that express the tetracycline repressor were main-
tained in Iscove’s modified DME containing 5% FBS and 0.2  g/ml blasti-
cidin, and cells were transfected with the pcDNA4/TO vector (Invitrogen)
encoding Lyn K-HA or Lyn-HA using the TransIT Transfection reagent
(Mirus; Yamaguchi et al., 2001), and cell clones were selected in 250  g/
ml Zeocin (Invitrogen) plus 0.2  g/ml blasticidin. Doxycycline, a deriva-
tive of tetracycline, was used for protein expression. COS-1 and HeLa cells
were transiently transfected with 0.2  g or 1.0  g of plasmid vectors using
TransIT. For inhibition of Lyn kinase activity, COS-1 cells transfected with
Lyn were cultured for 6 h, and treated with PP2 (Calbiochem; Hanke et al.,
1996) for the next 18 h.
Immunofluorescence and photobleaching experiments
Cells were fixed with 4% PFA, permeabilized with 0.1% saponin, and
mounted with ProLong antifade reagent (Molecular Probes) after immuno-
staining (Tada et al., 1999; Yamaguchi et al., 2001). Confocal and No-
marski differential-interference-contrast images were obtained using an
LSM510 (Carl Zeiss MicroImaging, Inc.) or Fluoview FV500 (Olympus) la-
ser scanning microscope with a 20  0.50 NA or a 40  0.75 NA objective,
or a 40  1.00 NA oil or a 100  1.35 NA oil immersion objective. Care
was taken to ensure that detection sensitivity was kept constant and that
there was no bleed-through from the fluorescein signal into the red chan-
nel (Yamaguchi et al., 2001). One planar (xy) section slice was shown in
most experiments. Orthogonal sections viewing axial directions (xz and
yz) were created when all Z-series sections at 0.25–0.5- m intervals were
merged. 100–800 cells were scored for each assay according to whether
expressed proteins were highly restricted in the perinuclear region or at the
plasma membrane. Results (%) were expressed as ratios of number of cells
exhibiting these classified localizations to total number of cells expressing
Lyn proteins. For FRAP experiments, COS-1 cells were transfected with
Lyn-GFP or Tetra-mt-GFP, and cultured for 1 d. Cells were maintained
above 30 C in a warmed room throughout photobleaching experiments
that were performed on a stage of a Fluoview FV500 laser scanning micro-
scope using the 488 nm line of an argon laser with a 40  1.00 NA oil im-
mersion objective to achieve sufficient depth for bleaching z. The circled
area or whole area was photobleached at full laser power (100% power)
and recovery of fluorescence was monitored by scanning the whole cell at
low laser power (3.0% power). Time-lapse sequences were recorded with
Fluoview Tiempo and the mean fluorescence intensities within regions of
interest were quantified using Fluoview Tiempo time course version 4.2
software. Composite figures were prepared using Photoshop 5.0 and Illus-
trator 9.0 software (Adobe).
Western blotting, immunoprecipitation, and in vitro kinase assay
Lysates were prepared in Triton X-100 lysis buffer (50 mM Hepes, pH 7.4,
10% glycerol, 1% Triton X-100, 4 mM EDTA, 100 mM NaF, and 1 mM
Na3VO4) containing 50  g/ml aprotinin, 100  g/ml leupeptin, 25  M pep-
statin A, and 2 mM PMSF. Immunoprecipitation was performed using anti-
Lyn– or anti-HA–precoated protein-G beads. Immunodetection was per-
formed as reported previously (Hirao et al., 1997; Mera et al., 2002). In
vitro kinase assays were performed as described previously (Iwama et al.,
1996; Hirao et al., 1997; Mera et al., 1999; Yamaguchi et al., 2001). In
brief, Lyn was immunoprecipitated with anti-Lyn from Triton X-100 lysates
of COS-1 cells transfected with Lyn or Lyn plus Csk. After washing, equal
amounts of each immunoprecipitate were reacted with acid-denatured
enolase in kinase buffer (50 mM Hepes, pH 7.4, 1% Triton X-100, 10 mM
MnCl2, 1 mM Na3VO4) containing 100  M unlabeled ATP at 30 C for the
indicated periods. Phosphorylated bands were immunodetected by anti-
pTyr, and quantified with the Image Gauge software using an Image Ana-
lyzer LAS-1000plus (Fujifilm). Composite figures were prepared using Pho-
toshop 5.0 and Illustrator 9.0 software (Adobe).
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